≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Mandibular retrognathia

EFO Endpoint Browser PheWeb

K11_MN_RETRGN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — K07.13
  • Hospital discharge: ICD-10 — K07.13
  • Cause of death: ICD-10 — K07.13

3 out of 7 registries used, show all original rules.

2787

4. Check minimum number of events

None

2787

5. Include endpoints

None

2787

6. Filter based on genotype QC (FinnGen only)

2787

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 54236 28196 25988
Only index persons 47897 25173 22724
Unadjusted period prevalence (%)
Whole population 0.77 0.81 0.73
Only index persons 0.90 0.93 0.87
Median age at first event (years)
Whole population 12.06 12.44 11.60
Only index persons 12.73 13.25 12.15

-FinnGen-

Key figures

All Female Male
Number of individuals 2787 1943 844
Unadjusted period prevalence (%) 0.57 0.66 0.37
Median age at first event (years) 35.13 33.98 37.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2476
Matched controls
24658
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
SBB10
NOMESCO Finland
Teeth copy
22.0
323.0
1600
1888
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
18.4
323.0
709
526
K07.23
ICD-10 Finland
Deep bite
26.4
323.0
1027
645
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
19.1
323.0
1014
864
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
20.8
323.0
836
589
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
17.2
323.0
843
720
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
12.6
323.0
739
802
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
13.1
323.0
1048
1310
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
21.8
323.0
1035
787
K07.13
ICD-10 Finland
Retrognaty, mandibular
+∞
323.0
2476
*
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
20.6
323.0
1042
842
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
14.9
323.0
875
871
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
14.0
323.0
611
562
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
22.1
323.0
896
618
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
18.6
323.0
600
417
EB1MA
NOMESCO Finland
Cephalometry with X-ray
17.3
323.0
877
756
SAA04
NOMESCO Finland
Special inverstigation of mouth
12.4
323.0
922
1126
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
528.9
323.0
907
27
K07.24
ICD-10 Finland
Open bite
29.6
310.9
427
172
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
7.2
308.1
879
1754
SJB60
NOMESCO Finland
External device grinding and adaptation
12.2
285.5
555
570
SJC00
NOMESCO Finland
Bracket with fixed attachment
117.7
263.1
283
27
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
9.5
257.9
577
762
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
20.6
254.4
391
222
SXC05
NOMESCO Finland
Other oral or dental procedure
6.7
248.5
728
1445
K07.60
ICD-10 Finland
Snapping jaw
9.5
235.5
524
677
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
15.4
221.0
380
287
SAA03
NOMESCO Finland
Extended examination of mouth
4.0
221.0
1716
8923
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
11.3
217.2
435
458
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
27.8
216.0
301
122
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
7.2
212.9
576
1000
EEC05
NOMESCO Finland
Le Fort I osteotomy
87.6
201.0
224
28
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.6
195.3
563
1056
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
6.4
193.5
573
1112
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
12.1
191.7
368
351
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
7.2
188.8
502
838
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
7.2
182.0
482
797
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
7.3
181.8
479
786
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
30.8
180.3
244
87
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
148.5
170.5
180
13
K07.10
ICD-10 Finland
Asymmetry of jaw
48.3
164.3
201
45
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
6.9
161.7
439
743
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.2
155.9
1261
6053
K07.14
ICD-10 Finland
Retrognaty, maxillary
38.0
143.2
184
52
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
74.8
142.3
162
23
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
16.8
136.0
223
144
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.8
131.1
1422
7946
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
55.1
130.7
156
30
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
7.5
128.5
324
484
EBB10
NOMESCO Finland
Insertion of dental implant
19.5
120.1
186
102
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
97.6
118.1
130
14
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
114.1
110.8
120
11
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
5.3
106.0
354
754
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
43.3
96.2
120
29
EBB15
NOMESCO Finland
Insertion of dental implant abutment
31.3
89.6
120
40
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
25.6
88.4
125
51
K07.04
ICD-10 Finland
Macrognathism (mandibular)(maxillary)
79.4
81.6
92
12
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
19.3
80.3
124
67
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.2
78.3
324
848
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
13.8
77.2
136
103
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
4.8
76.6
275
624
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
15.3
71.1
120
82
SJA02
NOMESCO Finland
Plan for orthodontic care
54.0
70.4
84
16
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
11.1
67.8
132
124
K00.00
ICD-10 Finland
Hypodontia
7.7
65.5
159
219
EBA10
NOMESCO Finland
Surgical removal of tooth
2.6
63.7
536
2336
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
48.7
62.6
76
16
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.0
62.0
266
714
OIKK
NOMESCO Finland
NA
3.5
60.8
319
1013
G47.3
ICD-10 Finland
Sleep apnoea
2.6
59.9
532
2382
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
8.8
55.8
123
145
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
71.3
55.2
63
9
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
10.1
54.9
112
115
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.8
54.5
404
1618
EDC30
NOMESCO Finland
Genioplasty
100.3
53.9
59
6
K07.27
ICD-10 Finland
Anomalies of dental arch relationship
7.1
53.7
137
203
SAA02
NOMESCO Finland
Basic examination of mouth
2.1
53.5
1951
15720
SXC03
NOMESCO Finland
Other oral or dental procedure
12.7
53.4
97
79
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
5.7
52.9
160
297
R06.5
ICD-10 Finland
Mouth breathing
3.2
52.2
306
1049
EB1WA
NOMESCO Finland
NA
16.8
50.9
82
50
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
3.5
48.9
251
778
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
12.2
48.2
89
75
K01.0
ICD-10 Finland
Embedded teeth
5.3
48.0
153
302
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
15.0
46.9
79
54
OIKH
NOMESCO Finland
NA
3.5
45.4
225
678
SJB30
NOMESCO Finland
Extraoral device arrangement and user information
6.7
44.6
118
184
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
21.1
44.4
66
32
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
47.1
42.0
51
11
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
6.2
41.0
114
190
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
7.4
41.0
100
139
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
40.9
262
948
SPB10
NOMESCO Finland
Production of temporary crone to tooth
14.1
40.1
69
50
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.0
39.2
165
432
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
35.9
1902
15904
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
7.1
35.0
88
128
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
3.7
34.5
161
460
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
12.9
34.3
61
48
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
18.0
34.0
53
30
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
33.9
785
5079
OIKAL
NOMESCO Finland
NA
4.1
33.7
137
347
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
27.2
31.4
43
16
J01CE02
ATC
phenoxymethylpenicillin; oral
1.7
30.8
1755
14549
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
10.7
30.4
59
56
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
7.6
30.3
72
97
EMAK
NOMESCO Finland
NA
3.5
30.2
150
451
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
8.2
29.7
67
83
SDA02
NOMESCO Finland
Parodonthologic therapy
1.7
29.3
876
6057
OIKAK
NOMESCO Finland
NA
21.2
28.6
42
20
OIKON
NOMESCO Finland
NA
8.7
28.1
61
71
OIKNV
NOMESCO Finland
NA
11.5
27.8
52
46
EFB50
NOMESCO Finland
Orthodontic procedure connected with ortognathic surgery
100.8
27.6
30
*
EEC02
NOMESCO Finland
Rapid expansion of maxilla
62.5
26.9
31
5
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.3
26.4
253
1144
K07.4
ICD-10 Finland
Malocclusion, unspecified
4.8
26.3
90
193
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
9.3
25.9
54
59
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.0
25.3
104
267
OIKJA
NOMESCO Finland
NA
7.3
24.7
60
84
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
10.1
24.7
49
49
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
11.4
24.6
46
41
WZA90
NOMESCO Finland
Other doctors statement
1.7
24.6
658
4364
OIKVA
NOMESCO Finland
NA
3.3
24.5
128
401
SJC20
NOMESCO Finland
Extraoral ofthodontisk pulling device arrangement and urser information
6.4
24.4
65
104
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.2
24.4
131
419
EBA00
NOMESCO Finland
Extraction of tooth
1.6
23.5
876
6327
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
9.9
23.4
47
48
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
11.5
22.6
42
37
SPAT1324
SPAT
Screening procedure
1.7
22.1
514
3252
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
2.9
21.9
136
479
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
7.5
20.8
49
66
OIKKK
NOMESCO Finland
NA
8.7
20.5
44
51
ZXA10
NOMESCO Finland
Bilateral
1.8
20.5
375
2196
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.7
20.2
146
565
K07.61
ICD-10 Finland
Cracking jaw joint
3.6
20.1
91
255
ZXX07
NOMESCO Finland
Extent of procedure, 7 units
48.2
20.1
24
5
K07.9
ICD-10 Finland
Dentofacial anomaly, unspecified
35.9
19.8
25
7
EDW99
NOMESCO Finland
Other operation on mandible
29.0
19.6
26
9
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
19.5
607
4147
K07.26
ICD-10 Finland
Anomalies of dental arch relationship
15.6
19.2
31
20
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
19.2
280
1512
M79.1
ICD-10 Finland
Myalgia
1.9
18.9
302
1682
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
18.9
674
4756
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
6.3
18.9
50
80
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
18.8
592
4051
F45.8
ICD-10 Finland
Other somatoform disorders
2.1
18.8
220
1084
EBA40
NOMESCO Finland
Excision of apex of root of tooth
6.1
18.4
50
83
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
13.6
18.2
31
23
SPAT1263
SPAT
Sampling
1.5
17.8
998
7763
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
17.7
1200
9694
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
8.2
17.7
39
48
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
10.7
17.4
33
31
SAALT
NOMESCO Finland
NA
3.3
17.2
89
279
G50.1
ICD-10 Finland
Atypical facial pain
4.5
17.1
61
139
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
5.5
17.0
50
92
EB1BD
NOMESCO Finland
Extensive cone beam CT of teeth and jaws (two quarters)
16.0
17.0
27
17
EGC30
NOMESCO Finland
Prosthetic replacement of mandibular joint
50.1
17.0
20
*
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
2.8
17.0
113
419
OIKPU
NOMESCO Finland
NA
6.7
16.7
42
63
K07.00
ICD-10 Finland
Macrognatia (hyperplasia) of the upper jaw
35.1
16.6
21
6
A02BC05
ATC
esomeprazole; systemic
1.5
16.4
746
5531
TEG00
NOMESCO Finland
Punction of mandibular joint
20.1
16.4
24
12
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
15.4
16.1
26
17
4344
FHL
Osteotomy and shaping of the lower jaw (jaw deformities)
30.1
16.1
21
7
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
4.7
15.9
53
113
OIKRE
NOMESCO Finland
NA
4.6
15.8
54
118
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
15.5
822
6270
N03AX16
ATC
pregabalin; oral
1.6
15.1
417
2738
EGA00
NOMESCO Finland
Arthroscopy of mandibular joint
17.8
15.1
23
13
K07.0
ICD-10 Finland
Major anomalies of jaw size
31.8
14.8
19
6
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
31.8
14.8
19
6
P01BA02
ATC
hydroxychloroquine; oral
2.1
14.7
173
853
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
14.2
14.5
24
17
J34.2
ICD-10 Finland
Deviated nasal septum
2.5
14.4
118
492
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.6
14.2
416
2772
K03.00
ICD-10 Finland
Approximal wear
2.3
14.0
135
610
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
14.0
437
2959
Z50.1
ICD-10 Finland
Other physical therapy
2.5
13.9
112
463
SCD01
NOMESCO Finland
Simple removal of tooth plaque or tartar
3.9
13.9
56
144
K07.29
ICD-10 Finland
Anomaly in the relationship between the tooth arches UNS
53.4
13.8
16
*
5240A
ICD-9 Finland
Dentofacial anomalies, including malocclusion, Major anomalies of jaw size
20.1
13.7
20
10
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
13.7
961
7688
-1
NOMESCO Finland
NA
1.4
13.6
980
7875
OIKTA
NOMESCO Finland
NA
7.3
13.2
31
43
SXB10
NOMESCO Finland
Removal of attachments and rails from moth
12.2
13.1
23
19
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.4
12.6
749
5791
K07.09
ICD-10 Finland
Anomaly in the size of the jaws UNS
32.0
12.5
16
5
J01FF01
ATC
clindamycin; systemic
1.5
12.4
518
3731
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
7.3
12.4
29
40
WX704
NOMESCO Finland
Intubation
2.0
12.1
156
802
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
15.9
12.1
19
12
SFA00
NOMESCO Finland
Small filling
1.6
12.0
294
1865
K06.00
ICD-10 Finland
Local gingivore traction
3.5
11.8
55
161
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
11.8
177
963
HMAK
NOMESCO Finland
NA
1.7
11.7
271
1695
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
11.7
1315
11263
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
11.6
218
1280
SPC08
NOMESCO Finland
Implant crown
12.5
11.6
20
16
KIP00
NOMESCO Finland
NA
13.6
11.4
19
14
SJD60
NOMESCO Finland
NA
120.0
11.4
12
*
K07.33
ICD-10 Finland
Crowding of tooth or teeth
7.0
11.3
27
39
XX7LW
NOMESCO Finland
NA
15.0
11.3
18
12
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
11.2
159
851
ECB05
NOMESCO Finland
Mucogingival repair
6.8
11.1
27
40
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
11.1
166
903
SJC04
NOMESCO Finland
NA
7.1
11.0
26
37
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.6
11.0
80
314
OIKLI
NOMESCO Finland
NA
11.9
10.8
19
16
A02BC03
ATC
lansoprazole; oral
1.5
10.7
459
3319
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.4
10.6
85
353
R01AD09
ATC
mometasone; nasal
1.3
10.6
1021
8492
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.6
10.6
76
298
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
10.5
262
1670
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.0
10.4
57
189
C07AA05
ATC
propranolol; systemic
1.5
10.3
415
2961
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
8.8
10.2
21
24
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.2
783
6274
L88
ICPC
Rheumatoid/seropositive arthritis
2.5
10.2
79
323
M01AE02
ATC
naproxen; oral, rectal
1.3
10.1
1376
12008
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
6.9
10.0
24
35
WX720
NOMESCO Finland
Own respiration
2.4
10.0
81
338
T84.62
ICD-10 Finland
Osteitis associated with dental implants
14.6
10.0
16
11
K05.30
ICD-10 Finland
Periodontitis complex
1.7
9.9
205
1239
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
6.7
9.9
24
36
N02BE01
ATC
paracetamol; systemic, rectal
1.3
9.8
1793
16306
ECA55
NOMESCO Finland
Complicated parodontal operation
7.0
9.7
23
33
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
9.7
790
6378
EDC45
NOMESCO Finland
Reconstruction of mandible using bone graft
55.0
9.6
11
*
EEC00
NOMESCO Finland
Segmental osteotomy of maxilla
100.0
9.4
10
*
ECU00
NOMESCO Finland
Removal of implant or external fixation device from alveoli
17.5
9.4
14
8
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
9.3
506
3814
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
9.3
662
5229
EB1KA
NOMESCO Finland
Partial (restricted area) panoramic tomography of teeth or jaw
4.9
9.2
29
60
OIKIN
NOMESCO Finland
NA
4.3
9.2
33
78
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.7
9.2
187
1129
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
9.1
101
491
K07.68
ICD-10 Finland
Other disorders of the jaw joint
4.5
9.1
31
70
R01AD12
ATC
fluticasone furoate; nasal
1.3
9.0
724
5818
SFB30
NOMESCO Finland
Filling of tree or more surfaces of tooth reproduced outside mouth
8.3
9.0
19
23
EEC45
NOMESCO Finland
Reconstruction of maxilla using bone graft
24.0
8.9
12
5
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.4
8.8
74
317
HAMTE
NOMESCO Finland
NA
4.4
8.8
30
68
J02AC01
ATC
fluconazole; systemic
1.3
8.8
860
7112
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
14.0
8.7
14
10
OIKSI
NOMESCO Finland
NA
10.0
8.5
16
16
SPC01
NOMESCO Finland
Fixed dental crown
3.8
8.5
34
90
SPC50
NOMESCO Finland
Pivot column
20.0
8.4
12
6
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.9
8.4
115
606
AA40B
NOMESCO Finland
NA
7.3
8.4
19
26
K07.05
ICD-10 Finland
Micrognatia (hypoplasia) of both jaws
90.0
8.4
9
*
KMAK
NOMESCO Finland
NA
1.3
8.4
1105
9498
N06AX21
ATC
duloxetine; oral
1.6
8.3
214
1374
SPE05
NOMESCO Finland
Demanding fitting and preparation of metal structure partial teeth prosthesis
12.7
8.3
14
11
EEW99
NOMESCO Finland
Other operation on maxilla
+∞
8.3
8
*
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
9.4
8.2
16
17
SPAT1153
SPAT
Removal of sutures
1.4
8.2
501
3847
K07.35
ICD-10 Finland
Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth
3.1
8.2
42
135
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
8.2
366
2656
UDC00
NOMESCO Finland
Ear microscopy
1.7
8.2
154
907
SPAT1301
SPAT
No procedures
1.3
8.1
640
5113
WX199
NOMESCO Finland
Other local analgesia
3.1
8.1
42
136
SPA02
NOMESCO Finland
Preparation for dental prosthetics
3.1
8.1
43
142
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.8
8.1
137
781
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.0
830
6897
C05AA08
ATC
fluocortolone; rectal, topical
1.6
8.0
224
1472
K07.32
ICD-10 Finland
Displacement of tooth or teeth
6.3
8.0
20
32
SCD02
NOMESCO Finland
Removal of tooth plaque or tartar
4.1
7.9
29
71
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
7.9
189
1190
G47.8
ICD-10 Finland
Other sleep disorders
3.8
7.9
31
81
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.8
607
4837
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
7.8
1209
10573
Z3231
NOMESCO Finland
Registered nurse
1.3
7.8
547
4293
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
7.8
145
853
EDC05
NOMESCO Finland
Segmental osteotomy of mandible
44.9
7.7
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.0
7.7
91
458
A02BC02
ATC
pantoprazole; systemic
1.3
7.6
1140
9914
L04AB01
ATC
etanercept; parenteral
2.9
7.6
44
153
POLI
NOMESCO Finland
NA
18.3
7.6
11
6
EB1TW
NOMESCO Finland
3D modelling of dentition
18.3
7.6
11
6
K07.2
ICD-10 Finland
Anomalies of dental arch relationship
25.0
7.6
10
*
N06AB10
ATC
escitalopram; oral
1.4
7.5
461
3538
EG1DG
NOMESCO Finland
Very extensive MRI examination of mandipular joint with high intensity magnet
8.8
7.5
15
17
SBA00
NOMESCO Finland
Microbiological examinations
2.7
7.4
49
186
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.0
7.3
39
130
A31
ICPC
General and Unspecified, Medical examin/health eval partial
2.0
7.3
86
433
ENC40
NOMESCO Finland
Uvulopalatopharyngoplasty
4.5
7.2
24
54
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
7.2
460
3555
ZXC60
NOMESCO Finland
Application of heat
3.0
7.2
39
132
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
7.2
97
513
EGC10
NOMESCO Finland
Arthroplasty of mandibular joint without graft
20.0
7.1
10
5
PLAK0
NOMESCO Finland
NA
3.3
7.1
33
100
ECA50
NOMESCO Finland
Parodontal operation
5.0
7.1
21
42
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
7.1
182
1170
SFB40
NOMESCO Finland
Filling of four surfaces reproduced outside mouth
5.3
7.0
20
38
K07.6
ICD-10 Finland
Temporomandibular joint disorders
3.6
7.0
29
80
SPE00
NOMESCO Finland
Fitting and preparation of metal structure partial teeth prosthesis
4.1
7.0
25
61
A45
ICPC
General and Unspecified, Observ/health educat/advice/diet
2.4
6.9
56
238
L04AA13
ATC
leflunomide; oral
2.5
6.9
52
212
A02BA02
ATC
ranitidine; systemic
1.5
6.9
263
1851
SPA05
NOMESCO Finland
Guiding rail
13.7
6.9
11
8
EGA05
NOMESCO Finland
Rinsing of mandipular joint
13.7
6.9
11
8
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
6.8
148
911
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
6.8
154
961
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
4.0
6.7
25
63
Z01.2
ICD-10 Finland
Dental examination
1.3
6.7
1044
9075
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
3.6
6.7
28
78
N06AB03
ATC
fluoxetine; oral
1.5
6.7
255
1795
RD211
NOMESCO Finland
NA
2.0
6.6
79
400
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
6.6
99
544
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
6.4
6.6
16
25
EB1S1
NOMESCO Finland
Photography of teeth
5.9
6.6
17
29
SPA40
NOMESCO Finland
Precision impression for dental prosthesis
5.5
6.6
18
33
A02BC01
ATC
omeprazole; systemic
1.3
6.5
431
3342
H02AB06
ATC
prednisolone; systemic
1.3
6.5
825
6992
ENC30
NOMESCO Finland
Plastic operation of pharynx
3.3
6.5
30
91
N06AA09
ATC
amitriptyline; systemic
1.6
6.5
143
884
PLAK2
NOMESCO Finland
NA
3.4
6.5
29
86
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
1.7
6.4
131
792
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
6.4
218
1494
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
3.9
6.4
24
61
R03BA01
ATC
beclometasone; inhalant
1.5
6.4
232
1614
EFW99
NOMESCO Finland
Other operation on jaws
69.7
6.4
7
*
YEA05
NOMESCO Finland
Excision of gingival or connective tissue for transplantation
14.3
6.4
10
7
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
6.4
125
748
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.4
79
408
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
6.3
304
2232
M01AC06
ATC
meloxicam; systemic, rectal
1.3
6.3
585
4759
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
6.3
593
4839
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
6.3
107
616
K10.29
ICD-10 Finland
Inflammatory condition of the jaws UNS
18.0
6.2
9
5
SPC09
NOMESCO Finland
Implant crown, demanding
18.0
6.2
9
5
XA420
NOMESCO Finland
Extensive sleep examination
3.8
6.2
24
63
DHB50
NOMESCO Finland
Turbinoplasty
2.2
6.2
56
251
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
2.4
6.1
47
194
VALMI
NOMESCO Finland
NA
1.3
6.1
692
5773
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
6.3
6.1
15
24
WX402
NOMESCO Finland
General anaesthesia
1.4
6.1
329
2467
WX110
NOMESCO Finland
Local anesthesy
1.2
6.1
1624
14922
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.4
6.1
48
204
5241A
ICD-9 Finland
Dentofacial anomalies, including malocclusion, Anomalies of relationship of jaw to cranial base
12.5
6.1
10
8
HAHOM
NOMESCO Finland
NA
2.6
6.0
41
161

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041096) Erythrocytes [Presence] in Urine by Automated
896
6091
1.69
33.68
3.5
2.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
115
336
3.52
32.95
4.5
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1121
8274
1.59
29.22
3.6
3.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1330
10627
1.47
21.72
3.6
3.1
estimate
0.0
0.0
0.80
298
1995
(3009261) Glucose [Presence] in Urine by Test strip
1332
10728
1.46
20.40
3.7
3.1
estimate
0.0
0.0
0.05
292
2000
(3021601) Nitrite [Presence] in Urine by Test strip
1320
10643
1.45
19.92
5.2
4.3
estimate
0.0
0.0
0.40
305
2068
(3025159) Blasts/100 leukocytes in Blood
270
1553
1.81
17.36
4.6
4.6
%
0.0
0.6
1.00
42
348
(3021440) Promyelocytes/100 leukocytes in Blood
279
1635
1.78
16.84
4.5
4.5
%
0.2
0.1
0.32
53
411
(3007930) Methemoglobin/Hemoglobin.total in Blood
128
577
2.27
16.24
3.7
6.9
%
0.9
0.9
0.23
118
540
(3017181) Myelocytes/100 leukocytes in Blood
286
1711
1.74
16.05
4.5
4.4
%
0.8
0.9
0.04
56
446
(3002179) Metamyelocytes/100 leukocytes in Blood
269
1586
1.76
15.88
4.4
4.2
%
0.8
0.6
0.38
40
331
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
127
580
2.24
15.63
3.7
6.9
%
1.4
1.7
3.66
116
541
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
497
3486
1.51
14.46
1.6
1.6
pmol/l
60369105.3
36453956.0
0.25
434
3034
(3015736) pH of Urine
1026
8285
1.37
13.62
3.2
2.9
—
5.6
—
0
5
(40760892) CBC W Ordered Manual Differential panel - Blood
719
5510
1.41
12.96
5.2
4.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
156
827
1.93
12.93
4.8
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
47
147
3.22
12.25
1.8
2.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
155
857
1.85
11.32
3.4
2.8
e6/l
0.2
0.2
0.07
148
825
(3027273) Bicarbonate [Moles/volume] in Venous blood
132
704
1.91
10.79
2.7
4.0
mmol/l
25.4
25.3
0.24
127
677
(3037467) Urinalysis macro (dipstick) panel - Urine
1667
14810
1.30
10.24
4.9
3.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1784
16003
1.31
10.16
4.5
3.8
mm/h
8.4
9.4
4.32
1691
14954
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
217
1377
1.62
9.70
3.3
3.6
mmol/l
1.2
1.2
0.66
196
1205
(3002385) Erythrocyte distribution width [Ratio]
2187
20258
1.35
9.55
14.2
13.1
%
13.3
13.4
1.93
2140
19830
(3032080) INR in Blood by Coagulation assay
798
6473
1.32
9.48
5.8
6.1
inr
1.1
1.1
0.35
274
2087
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1157
9875
1.29
9.35
4.1
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1197
10263
1.29
9.32
9.8
8.5
e9/l
0.0
0.0
0.48
1047
8390
(3004119) Hemoglobin [Mass/volume] in Venous blood
161
964
1.71
9.01
3.1
4.2
g/l
135.7
131.4
2.01
156
940
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1988
18220
1.31
8.96
4.3
3.9
pmol/l
14.5
14.4
0.59
1842
16865
(3029937) Albumin [Presence] in Urine by Test strip
700
5612
1.33
8.95
3.7
3.4
estimate
0.0
0.0
0.01
299
2015
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1296
11263
1.27
8.92
3.2
2.9
ug/l
75.6
85.1
1.08
1232
10642
(3047181) Lactate [Moles/volume] in Blood
97
511
1.92
8.29
3.9
7.7
mmol/l
1.2
1.2
0.07
85
446
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
753
6152
1.30
8.29
2.4
2.5
u/l
60.5
56.6
0.45
701
5741
(3015171) Extractable nuclear Ab [Units/volume] in Serum
153
950
1.64
7.50
1.3
1.3
u/ml
0.4
1.0
—
6
80
(3018010) Neutrophils/100 leukocytes in Blood
1263
11105
1.24
7.33
6.8
6.2
%
54.8
55.3
1.17
1214
10484
(3026008) Bacteria identified in Urine by Culture
680
5565
1.29
7.25
2.8
2.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1704
15516
1.24
7.06
6.6
6.8
u/l
76.0
78.4
1.54
1633
14688
(3002030) Lymphocytes/100 leukocytes in Blood
1274
11254
1.24
6.95
7.0
6.3
%
31.1
30.3
1.97
1229
10597
(40761511) CBC panel - Blood by Automated count
2527
24222
1.43
6.88
11.0
9.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
341
2551
1.38
6.74
1.6
1.6
nmol/l
1244.1
1172.2
0.86
276
2002
(3017446) Testosterone [Moles/volume] in Serum or Plasma
224
1554
1.48
6.73
2.6
2.1
nmol/l
13.2
11.6
1.99
202
1387
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2230
20996
1.29
6.73
4.9
4.5
mu/l
1.8
2.0
1.15
2110
19795
(1761868) Lipid panel - Serum or Plasma
992
8565
1.24
6.59
2.8
2.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
261
1880
1.42
6.43
1.4
1.3
u/ml
155.7
239.3
2.11
247
1750
(3006504) Eosinophils/100 leukocytes in Blood
1215
10750
1.22
6.32
7.1
6.4
%
2.9
2.9
0.73
1164
10082
(3019069) Monocytes/100 leukocytes in Blood
1222
10828
1.22
6.24
7.3
6.6
%
8.3
8.2
0.48
1173
10221
(3022096) Basophils/100 leukocytes in Blood
1175
10391
1.22
6.06
7.2
6.5
%
0.7
0.7
0.58
1128
9760
(3019198) Lymphocytes [#/volume] in Blood
1324
11863
1.21
5.94
7.0
6.3
e9/l
2.0
2.0
0.93
1246
10582
(3013115) Eosinophils [#/volume] in Blood
1323
11856
1.21
5.92
7.3
6.6
e9/l
0.2
0.2
0.24
1239
10546
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1041
9162
1.21
5.48
7.0
6.8
mmol/l
1.2
1.2
0.71
876
7873
(3006315) Basophils [#/volume] in Blood
1278
11477
1.20
5.42
7.1
6.3
e9/l
0.0
0.0
0.12
1185
10018
(3001604) Monocytes [#/volume] in Blood
1272
11446
1.20
5.20
7.1
6.3
e9/l
0.5
0.5
0.49
1184
10004
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
221
1613
1.40
5.09
2.9
3.2
pmol/l
4.7
4.6
0.50
200
1456
(3023103) Potassium [Moles/volume] in Serum or Plasma
2328
22231
1.27
5.02
11.1
11.3
mmol/l
3.9
3.9
1.00
2262
21602
(3026389) Candida sp identified in Specimen by Organism specific culture
58
308
1.90
4.98
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
457
3722
1.27
4.90
3.1
2.7
mosm/kgh2o
577.2
561.0
0.62
396
3196
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
42
200
2.11
4.88
2.1
1.6
%
32.8
54.4
2.54
28
132
(3030905) Polymorphonuclear cells [#/volume] in Blood
78
457
1.72
4.87
3.0
3.7
e9/l
3.4
3.9
1.21
78
457
(40758558) Short blood count panel - Blood
478
5724
0.80
4.76
7.3
6.8
—
—
—
0
0
(3039000) Anion gap in Blood
61
335
1.83
4.74
4.9
9.9
mmol/l
10.9
11.4
0.55
52
303
(3033658) Prothrombin time (PT) actual/Normal
428
5184
0.79
4.70
4.6
4.1
%
95.4
94.8
0.25
417
5059
(3018572) Chloride [Moles/volume] in Blood
61
336
1.83
4.70
4.9
9.9
mmol/l
106.2
105.5
0.47
52
304
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
29
4.14
4.60
7.3
7.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
78
466
1.69
4.56
3.6
3.9
%
51.2
55.4
2.33
78
466
(3013512) EKG study
558
4687
1.23
4.54
3.1
3.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
250
1908
1.34
4.37
3.9
3.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
69
404
1.72
4.36
3.4
3.1
mg/l
22.2
22.9
0.05
49
252
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
713
6176
1.20
4.23
2.6
2.8
ng/l
25.9
46.2
1.28
341
3163
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
478
3988
1.24
4.12
1.3
1.3
iu/ml
20.6
26.3
0.83
146
1194
(3019550) Sodium [Moles/volume] in Serum or Plasma
2311
22162
1.23
4.10
11.2
11.2
mmol/l
139.8
139.7
2.66
2251
21585
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
125
857
1.48
4.09
1.0
1.1
u/ml
9.1
4.3
0.43
15
123
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
148
1050
1.43
4.05
2.5
2.9
ng/l
77.1
130.7
2.70
135
926
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
20
75
2.67
3.96
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
334
2691
1.27
3.91
1.9
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
153
2078
0.72
3.86
3.3
3.6
%
30.2
32.1
1.65
109
1525
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
759
6664
1.19
3.82
1.4
1.4
u/ml
1.2
1.6
0.82
237
1731
(3013826) Glucose [Moles/volume] in Serum or Plasma
1263
11570
1.16
3.71
4.1
4.6
mmol/l
6.2
6.4
3.74
1143
10674
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
119
830
1.45
3.60
2.4
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
429
3588
1.23
3.60
2.5
2.7
ug/g
117.4
109.8
0.21
349
2846
(3037522) Nuclear Ab [Titer] in Serum
401
3332
1.23
3.58
1.4
1.4
titre
490.2
542.3
0.25
86
641
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1084
9855
1.16
3.45
5.2
5.9
umol/l
10.1
10.5
0.73
1034
9312
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2383
23012
1.22
3.44
11.3
10.8
mg/l
17.8
20.6
4.05
1836
17248
(3031040) Bacteria [#/volume] in Urine by Automated count
1499
13957
1.15
3.42
4.4
3.7
e6/l
902.6
763.4
0.11
27
151
(3004789) Transferrin [Mass/volume] in Serum or Plasma
326
2666
1.25
3.37
2.4
2.4
g/l
2.6
2.5
1.91
302
2489
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
589
5110
1.19
3.36
2.1
2.3
mg/l
2.7
2.8
0.04
533
4444
(3051101) Glucose [Moles/volume] in Cord blood
9
18
5.00
3.36
6.8
5.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
279
2253
1.26
3.23
2.2
2.2
nmol/l
357.1
375.0
0.81
262
2095
(3025941) Bacteria identified in Stool by Culture
180
1374
1.33
3.21
1.2
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
31
157
1.98
3.16
1.3
1.4
pmol/l
96.9
249.2
—
10
49
(3022948) Iron [Moles/volume] in Serum or Plasma
354
2945
1.23
3.14
2.5
2.4
umol/l
15.6
14.4
2.06
332
2746
(3006270) Folate [Moles/volume] in Blood
29
144
2.02
3.13
1.0
1.1
nmol/l
409.4
396.6
0.14
23
137
(3044889) 12 lead EKG panel
1466
13681
1.14
3.11
3.0
2.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
550
4776
1.18
3.09
1.6
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
985
8953
1.15
3.06
2.7
2.4
nmol/l
77.5
72.9
5.49
932
8328
(3024561) Albumin [Mass/volume] in Serum or Plasma
861
7752
1.16
3.05
4.9
5.1
g/l
37.1
36.9
0.51
816
7270
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
441
3760
1.20
3.04
1.2
1.3
u/ml
12.0
9.5
0.32
206
1538
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
824
7403
1.16
3.00
3.7
3.3
u/l
29.4
30.7
0.57
790
7071
(3039443) Prostate specific Ag panel - Serum or Plasma
51
310
1.65
2.92
1.8
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
106
759
1.41
2.85
1.4
1.8
g/l
0.2
0.2
0.15
98
719
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
11
36
3.05
2.79
9.2
5.7
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
11
36
3.05
2.79
9.1
5.6
—
—
—
0
0
(4281824)
6
190
0.31
2.79
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
36
201
1.80
2.78
2.6
2.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
53
2.64
2.77
1.8
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1388
12989
1.13
2.65
9.4
8.9
e9/l
3.7
3.9
3.25
1279
11350
(3019225) pH of Specimen
124
1627
0.75
2.57
2.3
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2043
19608
1.14
2.57
3.5
3.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
432
3734
1.18
2.56
1.4
1.5
nmol/l
21.1
20.3
0.54
392
3321
(21494814) CD8 cells/100 lymphocytes in Specimen
17
74
2.30
2.56
1.8
2.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
163
0.30
2.55
1.2
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
107
785
1.37
2.53
1.4
1.7
g/l
1.2
1.2
0.06
99
743
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
150
1910
0.77
2.51
2.3
2.4
u/l
36.5
61.2
0.48
126
1643
(4094501)
69
468
1.48
2.51
1.1
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
39
231
1.69
2.50
2.6
2.7
%
39.6
46.2
—
5
25
(3019150) Specific gravity of Urine by Refractometry
541
4776
1.16
2.46
3.3
3.2
kg/l
1.0
1.0
0.32
73
687
(3008152) Bicarbonate [Moles/volume] in Arterial blood
116
867
1.35
2.45
6.6
8.3
mmol/l
24.5
24.5
0.05
105
811
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
144
1.88
2.44
2.2
1.6
%
60.7
35.5
2.35
19
92
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
260
2157
1.22
2.40
1.2
1.2
iu/ml
86.7
154.1
3.20
95
815
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
368
3158
1.19
2.38
2.9
3.2
ng/l
193.7
553.2
3.32
201
1900
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
166
2064
0.79
2.31
5.1
4.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
316
2684
1.20
2.30
3.5
3.4
%
20.8
21.3
0.23
109
1056
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
389
3366
1.18
2.28
4.3
3.9
ug/l
1.7
1.9
0.68
361
3076
(3020650) Glucose [Presence] in Urine
14
59
2.37
2.27
1.2
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
56
820
0.67
2.27
8.4
11.4
mmol/l
23.9
24.3
0.54
49
788
(1175426) CD3 cells/100 lymphocytes in Blood
36
215
1.68
2.26
2.5
2.6
%
75.5
73.0
0.37
36
209
(3022145) Colonoscopy Study observation
259
2163
1.21
2.26
1.3
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
130
1003
1.31
2.23
1.8
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
204
1664
1.24
2.23
7.1
4.8
kpa
4.7
4.8
0.25
197
1609
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
465
4089
1.16
2.23
1.5
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
208
1701
1.24
2.22
2.6
2.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
35
209
1.68
2.21
1.3
1.4
u/ml
0.4
0.7
0.39
15
72
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
107
1.96
2.18
1.0
1.1
%
102.5
92.2
2.24
13
55
(3015377) Calcium [Moles/volume] in Serum or Plasma
680
6150
1.14
2.17
2.9
3.1
mmol/l
2.4
2.4
0.08
632
5561
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
122
1.89
2.14
4.0
2.1
u/field
1.2
2.3
—
9
72
(3045683) HLA typing for celiac disease panel - Blood or Tissue
34
204
1.67
2.12
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
36
220
1.64
2.10
1.6
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
129
1632
0.78
2.09
15.0
14.4
inr
1.1
1.2
0.27
35
258
(40768443) Skin Pathology biopsy report
103
777
1.33
2.09
1.2
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
43
2.56
2.08
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
43
2.56
2.08
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
43
2.56
2.08
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
43
2.56
2.08
1.2
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
35
213
1.65
2.07
2.6
2.6
%
9.0
11.1
0.65
19
138
(3034274) Bile acid [Moles/volume] in Serum --fasting
78
564
1.39
2.07
2.6
2.7
umol/l
6.2
5.4
0.24
54
431
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
55
0.00
2.06
0.0
2.6
—
773.0
—
0
45
(3040893) Potassium [Moles/volume] in Capillary blood
5
10
4.99
2.06
4.6
2.6
mmol/l
4.4
4.2
—
5
10
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
31
2.90
2.06
1.4
2.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
400
3506
1.16
2.01
2.6
3.0
ng/l
445.6
715.2
2.69
322
2858
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
98
1276
0.76
1.99
11.9
5.7
mmol/l
24.0
24.0
0.05
91
1211
(40768797) Stomach Pathology biopsy report
307
2639
1.18
1.97
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
29
473
0.61
1.96
2.7
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1640
15653
1.11
1.93
3.2
3.1
u/l
39.1
38.8
0.04
1562
14965
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
11
4.54
1.93
1.4
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
40
257
1.56
1.93
2.8
2.8
e9/l
1.4
1.2
0.65
31
158
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
43
639
0.67
1.92
1.1
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
171
0.41
1.90
1.3
1.4
nmol/l
1.3
1.4
—
7
159
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
20
106
1.89
1.89
1.1
1.1
%
110.3
91.1
3.58
12
54
(3000494) Fungus identified in Specimen by Culture
281
2408
1.18
1.88
1.6
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
287
2465
1.18
1.87
1.6
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
65
2.15
1.86
17.4
7.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
194
1608
1.22
1.86
1.2
1.2
titre
136.0
187.6
—
5
38
(3009542) Hematocrit [Volume Fraction] of Blood
2315
22547
1.14
1.84
12.3
11.5
%
39.8
40.2
1.40
1784
18387
(3021387) Prolactin [Units/volume] in Serum or Plasma
182
1503
1.22
1.82
1.6
1.6
mu/l
296.3
316.5
0.40
164
1357
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
72
528
1.37
1.79
1.3
1.2
u/ml
22.6
41.1
—
7
50
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
14
67
2.09
1.74
1.9
1.4
ug/l
8.3
8.8
0.27
14
67
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
97
748
1.30
1.74
2.0
2.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
15
74
2.03
1.73
2.2
1.4
%
2.4
9.4
—
5
16
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
48
0.00
1.69
0.0
2.4
—
3700.6
—
0
29
(42870588) Differential panel, method unspecified - Blood
811
7511
1.11
1.68
7.2
6.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
82
1.95
1.68
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
261
2249
1.17
1.66
1.5
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2659
26212
1.25
1.66
17.1
15.7
e9/l
260.5
261.7
0.48
2615
25564
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
115
914
1.27
1.64
1.4
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
147
1776
0.82
1.64
11.1
9.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
125
1004
1.25
1.64
1.6
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2662
26249
1.24
1.62
17.1
15.7
e9/l
6.5
6.6
1.89
2618
25546
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
281
2442
1.16
1.61
2.6
2.5
%
26.2
23.9
1.51
234
2135
(3024731) MCV [Entitic volume]
2660
26230
1.24
1.60
17.0
15.6
fl
89.7
89.7
0.26
2637
25911
(3003327) Ova and parasites identified in Stool by Light microscopy
120
963
1.25
1.59
1.9
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
100
785
1.28
1.59
1.6
1.6
iu/ml
0.0
0.1
0.93
16
149
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
559
5090
1.12
1.59
2.2
2.1
u/l
147.0
203.8
1.78
524
4845
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
529
4804
1.12
1.57
2.0
2.0
mg/l
0.8
0.9
0.60
387
3530
(3035941) MCH [Entitic mass]
2660
26234
1.24
1.56
17.0
15.6
pg
30.0
30.0
0.38
2637
25916
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
770
7137
1.10
1.56
1.8
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
321
2825
1.15
1.56
2.2
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
139
1138
1.23
1.55
1.6
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
70
917
0.75
1.54
1.5
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2660
26238
1.23
1.53
17.1
15.7
e12/l
4.6
4.6
0.35
2613
25544
(3050129) First trimester maternal screen panel - Serum or Plasma
175
1468
1.20
1.53
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
122
1490
0.81
1.53
2.3
2.4
ml/min/173m2
80.9
75.9
0.85
52
539
(3044242) Glucose [Moles/volume] in Arterial blood
14
71
1.97
1.52
2.3
2.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
71
1.97
1.52
1.4
1.9
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
42
0.00
1.52
0.0
1.7
—
12.2
—
0
29
(3044007) Cell count panel - Peritoneal fluid
0
42
0.00
1.52
0.0
2.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
43
0.00
1.52
0.0
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
223
1914
1.18
1.51
6.9
5.3
kpa
5.7
5.9
1.83
214
1854
(44806420)
7
27
2.59
1.51
2.6
2.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
29
185
1.57
1.49
2.0
2.1
pg
32.9
32.3
0.30
29
185
(3002032) Base excess in Venous blood by calculation
221
1899
1.17
1.48
6.9
5.3
mmol/l
1.6
1.8
0.65
182
1534
(3013139) Helicobacter pylori Ag [Presence] in Stool
176
1486
1.19
1.45
1.2
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2660
26249
1.22
1.44
17.2
15.8
g/l
136.6
136.2
0.91
2637
25935
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
16
3.12
1.43
3.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
59
2.03
1.42
2.4
3.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
17
95
1.79
1.41
1.3
1.6
pmol/l
16.4
13.7
1.58
17
79
(3003338) MCHC [Mass/volume]
2175
21193
1.11
1.41
14.3
13.3
g/l
333.6
333.3
0.98
2155
21006
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
206
1768
1.17
1.41
3.3
4.5
u/l
212.5
244.2
3.92
193
1693
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
85
666
1.28
1.40
1.3
1.2
u/ml
10.5
37.2
—
8
41
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
49
354
1.39
1.39
4.3
3.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
71
544
1.31
1.39
1.4
1.4
ug/g
287.0
308.8
0.37
34
283
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2436
23896
1.13
1.35
9.7
8.8
u/l
26.4
26.4
0.03
2366
23221
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
42
2.14
1.33
2.2
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
440
3996
1.12
1.32
3.0
2.6
e6/l
6.5
7.5
0.77
390
3504
(3012501) Base excess in Blood by calculation
55
410
1.34
1.31
3.0
4.0
mmol/l
1.8
2.2
0.76
36
261
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
117
1408
0.82
1.31
2.1
1.9
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
41
0.00
1.31
0.0
2.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
78
612
1.28
1.29
1.3
1.3
u/ml
4.1
12.5
—
10
104
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
77
604
1.28
1.28
1.3
1.3
u/ml
3.4
7.2
—
8
68
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
18
2.77
1.28
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
143
1201
1.20
1.28
2.3
1.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
29
193
1.50
1.27
2.2
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
211
1833
1.16
1.26
1.9
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
109
893
1.23
1.25
1.8
2.0
u/l
42.5
40.0
0.75
102
828
(4010399)
160
1360
1.18
1.25
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
622
5767
1.10
1.25
1.5
1.5
g/l
2.0
2.1
0.78
436
3563
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
64
492
1.30
1.25
1.1
1.1
u/ml
2.5
2.7
0.07
38
231
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19
301
0.63
1.23
2.0
2.9
u/ml
2.7
18.6
0.61
19
272
(3003694) ABO and Rh group [Type] in Blood
776
7272
1.09
1.23
1.7
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
45
329
1.37
1.22
1.4
1.2
—
32.0
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
576
5327
1.10
1.22
1.7
1.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
19
2.63
1.21
3.6
1.6
ng/l
127.8
93.3
—
5
19
(3023511) Choriogonadotropin [Units/volume] in Urine
131
1098
1.20
1.21
1.5
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
48
356
1.35
1.20
2.9
2.5
%
17.4
17.2
0.16
26
186
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
230
2020
1.15
1.20
2.7
2.6
ug/l
0.7
0.7
0.36
115
1144
(3021901) Oxygen saturation in Capillary blood
40
288
1.39
1.19
8.2
2.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
59
452
1.31
1.19
9.9
3.5
mmol/l
24.4
24.4
0.02
52
419
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
38
2.10
1.18
4.3
2.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
226
1988
1.15
1.16
2.5
2.2
u/l
6128.5
6377.1
0.05
86
726
(3023323) Follitropin [Units/volume] in Serum or Plasma
209
1829
1.15
1.15
1.4
1.5
iu/l
25.7
23.8
0.39
182
1524
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
5
20
2.49
1.14
1.0
1.1
—
44.6
—
0
8
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
154
0.52
1.13
1.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
154
0.52
1.13
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
154
0.52
1.13
1.4
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
141
1199
1.18
1.12
1.3
1.3
miu/ml
203.5
224.6
0.33
71
586
(3022621) pH of Urine by Test strip
152
1302
1.17
1.11
2.8
2.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
18
111
1.62
1.10
5.2
1.7
%
111.3
135.9
1.02
18
106
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
7
31
2.25
1.10
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
45
590
0.76
1.07
1.5
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
385
3516
1.11
1.07
1.7
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
735
6914
1.08
1.05
1.8
1.7
pmol/l
98.0
97.8
0.04
387
3757
(3000012) Reticulocyte production index
12
67
1.79
1.03
1.3
1.4
—
—
—
0
0
(4211845)
16
98
1.63
1.02
1.7
2.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
47
1.91
1.01
6.9
4.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
51
651
0.78
1.01
1.3
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
109
0.46
1.00
2.6
2.1
nmol/l
226.6
149.6
—
5
95
(3004809) Band form neutrophils/100 leukocytes in Blood
36
264
1.36
1.00
2.9
3.3
%
1.8
1.3
0.38
27
216
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
94
1119
0.83
0.99
1.4
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
50
636
0.78
0.97
1.4
1.5
nmol/l
0.3
0.4
0.17
36
507
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
101
847
1.20
0.97
6.6
12.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
31
0.00
0.96
0.0
1.3
—
52.7
—
0
26
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
31
0.00
0.96
0.0
1.5
—
22.5
—
0
21
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
211
1876
1.13
0.95
1.9
1.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
35
258
1.36
0.95
1.0
1.1
u/ml
0.6
3.3
1.59
11
113
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
559
5225
1.08
0.94
1.7
1.6
mmol/l
1.3
1.4
1.02
479
4565
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
12
197
0.61
0.94
12.5
12.5
nmol/l
634.8
821.6
1.10
12
189
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
32
431
0.74
0.94
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
16
245
0.65
0.94
2.8
3.8
u/ml
15.3
1232.7
0.66
11
230
(1616796) Gas panel - Central venous blood
53
416
1.28
0.94
3.8
3.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
116
0.51
0.94
1.3
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
119
0.50
0.93
1.2
1.1
iu/ml
110.9
225.0
—
6
119
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
196
0.61
0.93
1.3
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
24
166
1.45
0.93
2.1
1.6
mmol/l
7.3
6.2
0.49
18
125
(3019832) Treponema pallidum Ab [Presence] in Serum
454
4214
1.09
0.91
1.7
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
78
1.66
0.90
2.6
2.2
umol/l
15.2
18.1
0.40
13
78
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
59
473
1.25
0.89
1.4
1.3
u/ml
2.3
3.6
—
5
36
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
280
3058
0.90
0.89
3.4
2.8
e6/l
3.0
3.6
0.49
175
1600
(3006184) Hemoglobin [Mass/volume] in Capillary blood
54
429
1.26
0.88
2.3
2.2
g/l
132.9
134.1
0.19
47
334
(3011985) Renin [Units/volume] in Plasma
35
262
1.34
0.88
2.8
1.6
mu/l
97.1
43.7
0.93
35
239
(3009214) Lutropin [Units/volume] in Serum or Plasma
133
1154
1.16
0.87
1.4
1.7
u/l
8.6
8.7
0.02
103
936
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
130
0.54
0.87
1.3
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
714
6758
1.07
0.87
2.0
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
17
111
1.53
0.86
1.9
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
95
1.58
0.86
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
73
603
1.21
0.85
2.0
1.5
u/ml
112.7
102.8
0.72
18
99
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
458
4877
0.92
0.84
2.4
2.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
31
1.93
0.84
1.3
1.2
—
—
—
0
0
(4306422)
31
410
0.75
0.83
1.1
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
89
1042
0.85
0.82
1.4
1.5
—
—
—
0
0
(4035726)
137
1551
0.87
0.81
1.6
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
32
1.87
0.81
1.3
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
11
65
1.69
0.81
1.1
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
236
0.67
0.81
1.7
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
23
163
1.41
0.80
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
212
0.66
0.80
1.3
1.7
—
—
—
0
0
(3010421) pH of Blood
60
489
1.23
0.80
2.9
4.0
ph
7.4
7.4
0.11
55
407
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2065
20234
1.07
0.80
3.7
3.6
mmol/l
5.6
5.7
1.43
1937
18900
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
130
1.46
0.79
1.8
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
39
302
1.29
0.79
1.1
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
10
58
1.72
0.79
2.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
99
0.50
0.77
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
103
887
1.16
0.77
4.9
6.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
27
0.00
0.77
0.0
1.2
—
1.8
—
0
27
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
100
1152
0.86
0.77
1.9
2.1
ug/l
5.0
6.9
1.24
93
1031
(3024891) Influenza virus A+B Ag [Presence] in Specimen
59
712
0.82
0.77
1.4
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
34
1.76
0.76
1.3
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
28
0.00
0.76
0.0
2.3
—
0.9
—
0
28
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
298
3215
0.91
0.76
3.2
2.6
e6/l
1.0
1.2
0.34
195
1752
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
32
243
1.32
0.75
1.1
1.1
mg/l
212.0
236.6
0.45
27
217
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
447
0.78
0.75
4.3
5.4
u/ml
0.3
0.3
1.24
20
247
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
295
2714
1.09
0.75
1.9
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
48
590
0.81
0.75
1.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
95
1094
0.86
0.73
11.4
4.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
133
0.60
0.73
1.9
1.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
28
367
0.76
0.73
4.8
5.5
umol/l
429.4
384.1
0.77
23
325
(36304419) Bacteria [Presence] in Urine
511
5387
0.93
0.73
3.4
2.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
135
0.59
0.73
1.3
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
370
3447
1.08
0.71
2.3
2.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
90
774
1.16
0.70
15.1
9.5
mg/l
1.2
1.2
0.74
84
744
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
26
1.92
0.70
2.2
2.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
307
0.74
0.69
1.1
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
488
4599
1.07
0.69
4.0
4.1
mg/mmol
6.9
9.2
0.69
323
3028
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
27
1.85
0.68
1.4
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
85
1.53
0.68
1.8
2.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
116
0.60
0.68
1.6
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
69
1.59
0.67
3.9
3.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
82
947
0.86
0.67
1.9
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
32
248
1.29
0.67
1.1
1.5
pmol/l
482.8
336.0
0.36
23
200
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
36
284
1.27
0.66
1.7
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
43
1.62
0.66
1.3
1.3
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
28
1.78
0.66
3.6
2.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
205
1.32
0.66
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
205
1.32
0.66
1.1
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
21
153
1.37
0.66
3.4
3.1
%
17.2
12.1
0.49
21
148
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2047
20102
1.06
0.65
9.0
9.1
ml/min/173m2
93.3
92.3
1.31
1694
15958
(3030313) Adrenal Ab [Titer] in Serum
7
44
1.59
0.65
1.1
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
44
1.59
0.65
1.1
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
74
632
1.17
0.64
2.0
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
27
206
1.31
0.64
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
12
177
0.67
0.64
1.3
2.0
mg/l
37.4
20.8
—
5
51
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
29
1.72
0.63
1.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
130
0.61
0.63
2.1
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
81
928
0.87
0.61
1.5
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
175
0.68
0.61
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
50
1.60
0.61
1.3
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
311
0.77
0.60
1.6
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
163
0.67
0.60
1.4
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
2.2
—
19.3
—
0
20
(3035637) Corticotropin [Mass/volume] in Plasma
43
352
1.22
0.60
1.5
1.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
32
253
1.26
0.60
1.1
1.2
mg/l
38.4
39.9
0.08
25
213
(3005719) IgG [Mass/volume] in Serum or Plasma
199
1822
1.10
0.59
3.2
2.8
g/l
9.9
10.3
1.08
184
1695
(3014576) Chloride [Moles/volume] in Serum or Plasma
219
2015
1.09
0.59
5.0
7.5
mmol/l
105.1
104.7
0.69
213
1974
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
42
507
0.82
0.59
1.0
1.0
u/ml
0.1
0.4
—
9
136
(3014111) Lactate [Moles/volume] in Serum or Plasma
138
1522
0.90
0.58
5.4
8.2
mmol/l
1.2
1.3
0.47
131
1453
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
6
35
1.71
0.57
1.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
35
1.71
0.57
2.0
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
18
241
0.74
0.57
1.2
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
54
1.48
0.57
1.0
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
33
264
1.25
0.57
1.4
1.4
g/l
2.7
2.8
0.16
24
186
(3024139) IgG subclass 3 [Mass/volume] in Serum
33
264
1.25
0.57
1.4
1.4
g/l
0.4
0.4
0.17
24
185
(4268621)
22
285
0.77
0.56
1.9
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
74
641
1.15
0.56
1.9
1.9
iu/l
3.0
4.9
2.63
28
247
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
77
669
1.15
0.56
1.7
1.6
titre
604.0
347.0
—
5
20
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
139
1528
0.90
0.56
14.0
8.7
mmol/l
24.6
24.9
0.47
139
1523
(3026470) Cobalt [Mass/volume] in Blood
8
55
1.45
0.56
2.5
2.2
ug/l
1.1
4.2
—
8
49
(40768806) Pleura Pathology biopsy report
5
89
0.56
0.56
1.0
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
144
1303
1.11
0.56
3.8
3.3
e9/l
66.4
71.5
1.01
112
946
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
262
0.76
0.55
1.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
29
229
1.27
0.55
2.4
1.9
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
33
265
1.24
0.55
1.4
1.4
g/l
6.2
6.3
0.09
24
187
(3042631) Mycobacterium sp identified in Specimen
11
159
0.69
0.54
6.1
3.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
204
1.27
0.53
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
204
1.27
0.53
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
204
1.27
0.53
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
222
1.26
0.52
1.6
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
146
0.68
0.52
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
57
487
1.17
0.52
2.1
1.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
100
891
1.12
0.52
1.2
1.1
u/ml
0.6
2.7
4.20
51
428
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
143
1.33
0.51
1.1
1.1
miu/ml
2331.7
1474.5
2.02
19
143
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
19
143
1.33
0.51
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
191
0.73
0.51
2.9
2.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
40
1.50
0.51
2.3
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
84
741
1.13
0.51
5.5
4.7
g/l
0.2
0.4
1.13
47
382
(3023430) Cat dander IgE Ab [Units/volume] in Serum
64
554
1.16
0.51
1.1
1.1
u/ml
7.8
7.1
0.09
39
258
(3023410) Appearance of Cerebral spinal fluid
23
291
0.79
0.51
3.3
2.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
170
1.29
0.50
1.0
1.1
u/l
1.1
1.0
0.08
11
83
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
156
0.70
0.50
1.5
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
261
2440
1.07
0.50
1.2
1.2
—
—
—
0
0
(4062490)
33
269
1.23
0.50
1.4
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
19
144
1.32
0.49
1.3
1.3
—
67.2
—
0
18
(3047007) Chlamydophila sp Ab [Presence] in Serum
43
506
0.84
0.49
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
101
1.38
0.48
1.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
12
166
0.72
0.48
2.2
1.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
44
371
1.19
0.48
3.4
3.2
nmol/l
21.1
25.2
1.50
44
362
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
29
354
0.81
0.48
2.4
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2114
20838
1.05
0.48
3.9
3.7
mmol/l
4.8
4.8
0.44
2010
19812
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
125
1366
0.91
0.47
4.1
4.1
ug/l
15.4
16.8
0.05
96
1028
(3018677) aPTT in Platelet poor plasma by Coagulation assay
296
2786
1.07
0.47
2.8
2.7
s
28.6
29.7
3.59
282
2708
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
28
226
1.24
0.47
1.0
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
34
407
0.83
0.47
2.4
3.3
umol/l
29.1
33.7
0.71
29
364
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
102
1.37
0.46
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
281
1.21
0.46
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
128
1393
0.91
0.45
9.9
4.5
mmol/l
1.3
1.4
0.06
96
1000
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2025
19951
1.04
0.45
3.5
3.4
mmol/l
1.2
1.3
0.63
1924
18860
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
84
0.59
0.45
1.4
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
84
0.59
0.45
1.4
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
84
0.59
0.45
1.4
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
84
0.59
0.45
1.4
2.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
84
0.59
0.45
1.2
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
16
120
1.33
0.45
2.1
2.5
ml
498.0
600.3
—
9
83
(40768800) Prostate Pathology biopsy report
14
186
0.75
0.45
1.4
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
50
1.40
0.45
1.3
1.0
—
—
—
0
0
(4024509)
11
152
0.72
0.44
1.7
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
245
2594
0.94
0.44
8.7
7.1
mmol/l
1.1
1.1
0.16
230
2453
(3037756) Immunofixation for Serum or Plasma
17
219
0.77
0.44
1.4
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
52
449
1.16
0.44
1.2
1.1
—
—
—
0
0
(4146454)
10
140
0.71
0.44
1.5
2.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
27
328
0.82
0.44
1.2
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
86
770
1.12
0.43
1.1
1.1
u/ml
2.8
2.8
0.00
32
212
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1862
18323
1.04
0.43
4.8
4.5
mmol/mol
37.8
38.1
0.52
1764
17340
(3021879) Hepatitis B virus core Ab [Presence] in Serum
210
2231
0.93
0.42
1.6
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
22
175
1.26
0.42
1.2
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
6
93
0.64
0.42
1.5
3.3
—
17.6
—
0
10
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
303
1.19
0.42
2.0
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
576
5544
1.05
0.42
2.1
2.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
47
405
1.16
0.42
1.4
1.7
g/l
0.6
0.8
0.80
29
310
(1002224) Polysomnography panel
114
1040
1.10
0.41
1.1
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
36
422
0.85
0.41
1.5
1.8
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
11
(3023419) Bacteria identified in Sputum by Culture
25
203
1.23
0.41
3.0
4.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
58
509
1.14
0.41
1.6
2.5
nmol/l
0.7
0.8
0.61
49
432
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
52
453
1.15
0.40
1.2
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
50
570
0.87
0.40
2.1
1.8
e6/l
72.5
1189.9
1.50
42
464
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
103
1124
0.91
0.40
1.7
1.7
mg/l
2.6
4.4
1.63
70
754
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
54
612
0.88
0.40
1.5
2.2
g/l
1.2
1.4
1.30
47
547
(44790047)
34
286
1.19
0.40
1.9
1.6
—
—
—
0
0
(44790049)
34
286
1.19
0.40
1.9
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
569
0.87
0.40
2.1
1.7
e6/l
2.1
18.7
2.99
42
441
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
174
1855
0.93
0.39
2.6
2.9
g/l
0.2
0.2
0.61
164
1756
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
523
5032
1.04
0.39
2.1
2.2
—
—
—
0
0
(44790048)
34
287
1.18
0.39
1.9
1.6
—
—
—
0
0
(44806118)
34
287
1.18
0.39
1.9
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
70
778
0.89
0.39
1.6
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
214
0.79
0.38
4.1
3.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
169
1575
1.07
0.38
1.9
2.5
e9/l
3.9
4.1
0.53
147
1334
(3009508) Creatinine [Moles/volume] in Urine
589
5688
1.04
0.37
3.1
3.4
mmol/l
8.3
8.2
0.11
520
4983
(3045142) Bone marrow Pathology biopsy report
15
191
0.78
0.37
1.7
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
72
795
0.90
0.36
1.1
1.1
u/ml
0.3
1.4
3.60
34
399
(3051611) Lipemic interference index of Serum or Plasma
15
190
0.79
0.36
6.8
3.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
23
277
0.83
0.36
1.7
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
195
1832
1.07
0.36
4.7
3.8
%
1.6
1.7
0.27
180
1673
(3016018) Differential panel - Cerebral spinal fluid
22
266
0.82
0.36
1.8
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
71
1.26
0.36
1.8
3.2
ug/l
182.9
94.9
—
9
71
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
60
534
1.12
0.36
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
135
1445
0.93
0.35
3.0
3.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
487
1.13
0.35
1.9
1.8
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
80
0.62
0.35
1.0
1.1
%
—
18.7
—
0
6
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
383
0.86
0.35
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
383
0.86
0.35
1.7
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
133
1423
0.93
0.35
9.8
4.4
ph
7.4
7.4
0.03
16
148
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
37
425
0.87
0.35
1.5
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
117
1.28
0.34
2.5
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
125
1158
1.08
0.34
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
226
2373
0.94
0.34
3.8
3.3
umol/l
6.7
6.9
0.04
193
2039
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
221
0.81
0.34
1.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
73
1.37
0.34
1.1
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
40
348
1.15
0.33
1.9
1.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
45
1.33
0.33
2.0
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
45
1.33
0.33
2.0
3.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
22
181
1.21
0.33
1.3
1.5
g/l
0.9
1.0
0.15
22
181
(3018095) Leukocytes [#/volume] in Urine
739
7185
1.03
0.33
4.0
3.6
e6/l
37.4
74.7
2.01
524
4808
(3009871) Measles virus Ab [Titer] in Serum
11
82
1.34
0.33
1.8
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
47
414
1.13
0.33
1.7
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
30
255
1.17
0.33
1.0
1.1
u/ml
0.8
4.3
—
10
96
(3022493) Free Hemoglobin [Mass/volume] in Plasma
12
91
1.32
0.33
1.3
4.8
mg/l
80.4
79.4
0.02
12
70
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
136
1.25
0.33
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
28
237
1.18
0.32
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
37
422
0.87
0.32
1.2
1.3
u/ml
5.0
4.3
—
10
149
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
127
1182
1.07
0.32
2.4
2.5
u/ml
26.2
39.5
1.17
121
1146
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
463
0.88
0.31
1.2
1.8
g/l
2.9
3.1
0.88
31
373
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2094
20703
1.03
0.31
3.9
3.6
mmol/l
1.5
1.5
0.87
1987
19603
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
54
483
1.12
0.31
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
119
1.26
0.31
1.1
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
536
5191
1.04
0.30
4.1
3.8
ph
7.4
7.4
0.25
132
997
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
70
636
1.10
0.30
1.8
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
67
608
1.10
0.30
1.1
1.1
u/ml
15.3
4.9
0.71
42
258
(3048929) Epstein Barr virus Ab [Presence] in Serum
154
1448
1.06
0.30
1.6
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
29
249
1.16
0.29
3.7
4.1
u/ml
28.6
133.9
—
7
70
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
21
175
1.20
0.29
1.2
1.2
ratio
1.1
1.0
—
6
73
(3041806) Other cells [#/volume] in Blood by Manual count
21
175
1.20
0.29
1.3
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
24
203
1.18
0.29
1.2
1.1
—
33.8
—
0
5
(3043238) Trisomy 21 risk [Likelihood] in Fetus
87
936
0.92
0.28
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
130
1.23
0.28
2.0
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
317
3046
1.04
0.28
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
345
1.13
0.27
1.6
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
438
4238
1.04
0.27
3.8
4.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
167
1753
0.95
0.27
1.3
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
128
0.78
0.27
2.9
4.4
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
9
120
0.75
0.27
1.0
1.1
u/ml
4.2
16.2
—
9
87
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2121
20993
1.03
0.27
4.2
3.9
mmol/l
2.9
2.9
0.14
2009
19819
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
87
933
0.93
0.26
1.9
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
23
267
0.86
0.26
1.6
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
15
122
1.23
0.26
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
67
1.19
0.26
4.1
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
37
414
0.89
0.26
2.6
2.2
—
—
—
0
0
(3020891) Body temperature
54
591
0.91
0.26
4.4
5.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
71
0.70
0.26
1.6
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
603
5872
1.03
0.26
3.7
3.1
e6/l
25.7
67.5
2.03
492
4430
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
41
366
1.12
0.25
1.3
1.4
mmol/l
6.2
6.9
0.99
23
259
(42529406) Shigella sp [Presence] in Stool by Culture
64
694
0.92
0.25
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
50
452
1.10
0.25
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
139
1312
1.06
0.25
5.8
4.7
ng/l
71.2
74.2
0.21
122
1203
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
56
510
1.10
0.25
1.5
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
160
1.19
0.24
6.1
5.5
%
11.7
11.4
0.13
19
160
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
136
1430
0.95
0.24
9.5
4.5
kpa
5.1
5.1
0.34
128
1356
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
77
1.17
0.24
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
77
1.17
0.24
1.2
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
153
1602
0.95
0.24
11.9
9.3
mmol/l
6.8
7.2
0.47
148
1547
(3045424) Erythrocytes [Presence] in Urine
39
349
1.12
0.24
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
191
1823
1.05
0.24
1.4
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
85
0.70
0.24
2.7
2.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
60
649
0.92
0.23
1.4
1.3
—
1089.4
—
0
18
(4034850)
58
628
0.92
0.23
7.4
8.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
527
5377
0.97
0.23
3.5
3.0
e6/l
0.2
0.3
0.88
423
3986
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
22
253
0.87
0.23
1.1
1.1
iu/ml
3.1
9.0
—
7
55
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
168
0.83
0.23
1.4
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
15
124
1.21
0.23
2.4
3.0
u/ml
954.6
965.8
0.01
15
124
(3015076) Soybean IgE Ab [Units/volume] in Serum
26
227
1.14
0.23
1.1
1.0
u/ml
0.1
1.0
—
5
38
(3012516) Albumin [Mass/volume] in Urine
452
4393
1.03
0.23
3.0
3.4
mg/l
1000.1
303.2
1.12
278
2878
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
18
210
0.85
0.22
1.3
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
12
146
0.82
0.22
2.8
3.1
mg/l
42.4
46.5
—
7
105
(3029075) Extractable nuclear Ab panel - Serum
7
93
0.75
0.22
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
64
688
0.93
0.22
1.1
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
7
95
0.73
0.22
1.0
1.1
u/l
35.9
22.9
—
7
82
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
16
134
1.19
0.22
1.1
2.1
nmol/l
0.1
0.2
—
10
108
(21494890) Protein electrophoresis panel - 24 hour Urine
10
124
0.80
0.22
1.7
2.1
—
—
—
0
0
(4027681)
24
209
1.15
0.22
1.3
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
88
1.25
0.22
1.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
25
283
0.88
0.22
1.1
1.3
nmol/l
—
0.4
—
0
9
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
247
1.13
0.22
1.3
1.4
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
10
0.00
0.21
0.0
1.5
—
2489.8
—
0
10
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.1
—
1.3
—
0
6
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
8.0
—
0
6
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
191
1.15
0.21
1.2
2.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
43
1.16
0.21
1.0
2.7
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
13
0.00
0.21
0.0
1.5
—
10.2
—
0
6
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
880
0.94
0.20
1.5
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
229
0.87
0.20
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
89
1.23
0.20
1.4
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
5.4
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
7.9
—
0
8
(3044640) Blood type and Crossmatch panel - Blood
652
6384
1.02
0.20
2.4
2.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
49
1.22
0.20
9.3
6.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
155
1482
1.05
0.19
6.5
9.8
%
96.4
96.2
0.11
141
1435
(3024928) Oxygen saturation in Venous blood
35
384
0.91
0.19
4.6
4.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
34
307
1.11
0.19
2.3
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
52
1.15
0.19
1.3
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
49
528
0.92
0.19
2.3
2.2
ug/l
4.4
2.1
0.47
42
481
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
107
1120
0.95
0.18
1.4
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
81
1.23
0.18
1.3
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
10
121
0.82
0.18
1.1
1.1
—
12.7
—
0
24
(3002173) Hemoglobin [Mass/volume] in Arterial blood
146
1397
1.04
0.18
6.6
10.0
g/l
124.7
123.4
0.35
135
1352
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
142
0.84
0.18
2.0
2.6
%
42.2
43.0
—
7
44
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
251
1.11
0.18
2.0
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
64
680
0.94
0.18
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
838
8243
1.02
0.17
2.0
1.9
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
18
204
0.88
0.16
1.0
1.0
mg/l
294.3
292.3
0.02
18
189
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
57
532
1.07
0.16
1.6
1.4
—
7.5
—
0
12
(3002523) Influenza virus A Ag [Presence] in Specimen
52
555
0.93
0.16
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
68
1.17
0.16
1.5
2.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
243
1.11
0.16
1.3
1.4
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
8
70
1.14
0.16
1.6
2.8
mmol/l
29.6
20.7
—
8
62
(3003740) Influenza virus B Ag [Presence] in Specimen
52
554
0.93
0.16
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
72
1.11
0.16
1.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
108
1124
0.96
0.16
1.4
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
182
0.88
0.15
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
139
1335
1.04
0.15
1.8
2.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
92
1.19
0.15
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
244
1.10
0.15
1.3
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
131
1257
1.04
0.15
1.7
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
87
909
0.95
0.15
1.4
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
81
1.11
0.15
1.2
1.0
—
—
—
0
0
(4198724)
24
216
1.11
0.15
2.7
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
79
827
0.95
0.14
1.1
1.1
u/ml
6.2
7.7
0.29
44
490
(3026493) Urate [Moles/volume] in Serum or Plasma
455
4615
0.98
0.14
2.5
2.6
umol/l
2638.3
3530.5
0.31
416
4137
(3051651) Icteric interference index of Serum or Plasma
12
139
0.86
0.14
8.0
3.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
159
1.13
0.14
2.1
2.9
%
49.5
54.1
—
10
110
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
11
128
0.86
0.14
1.0
1.3
%
—
69.4
—
0
13
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
128
0.86
0.14
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
251
2443
1.03
0.14
1.3
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
96
0.83
0.13
1.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
96
0.83
0.13
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
39
417
0.93
0.13
1.2
1.3
u/ml
3.2
4.3
0.54
12
182
(3005033) Fetal Nuchal fold Thickness US
87
906
0.96
0.13
1.4
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
8
97
0.82
0.13
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
98
0.81
0.13
6.0
4.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
81
845
0.95
0.13
2.1
2.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
8
99
0.80
0.13
1.0
1.1
u/l
93.5
78.8
—
8
86
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
25
273
0.91
0.13
1.2
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
345
0.92
0.13
2.9
3.3
mg/l
45.1
30.4
0.27
24
274
(3034860) Kappa light chains.free [Mass/volume] in Serum
32
345
0.92
0.13
2.9
3.3
mg/l
26.5
72.5
1.34
24
275
(3000492) Spirometry study
237
2306
1.03
0.13
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
86
895
0.96
0.13
1.4
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
14
122
1.14
0.13
1.7
2.9
mmol/l
38.9
36.5
0.13
14
117
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
109
0.82
0.13
1.0
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
281
2859
0.98
0.12
2.3
2.6
mmol/l
2.4
2.4
0.10
252
2506
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
109
1125
0.96
0.12
1.4
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
13
147
0.88
0.12
1.0
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
12
104
1.15
0.12
1.4
2.9
mmol/l
2.3
2.6
0.30
12
97
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
109
1124
0.97
0.11
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
23
250
0.92
0.11
1.8
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
157
0.89
0.11
1.4
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
175
1701
1.03
0.11
1.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
95
1.15
0.11
2.1
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
34
362
0.94
0.11
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
239
0.92
0.11
1.4
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
823
8279
0.99
0.11
6.9
6.3
mmol/l
1.2
1.2
0.05
754
7636
(44813793)
27
250
1.08
0.10
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
279
0.93
0.10
1.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
74
710
1.04
0.10
1.8
1.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
176
0.91
0.10
1.1
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
482
0.95
0.10
1.2
1.8
g/l
7.2
7.3
0.20
31
388
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
482
0.95
0.10
1.2
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
482
0.95
0.10
1.2
1.8
g/l
3.7
3.8
0.04
31
364
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
106
1.13
0.09
2.0
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
48
1.04
0.09
1.0
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
55
1.09
0.08
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
45
428
1.05
0.08
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
340
1.06
0.08
2.2
1.9
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
14
154
0.91
0.08
1.3
1.2
—
56.3
—
0
14
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
97
1.13
0.08
1.1
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
123
0.89
0.08
3.0
2.6
ug/l
21.6
85.5
0.49
11
109
(3017704) Immunofixation for Urine
5
62
0.80
0.08
1.2
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
64
0.78
0.08
1.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
64
0.78
0.08
1.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
45
469
0.96
0.08
1.2
1.3
—
—
—
0
0
(3036603) Volume of Urine
12
133
0.90
0.08
1.6
1.4
ml
2128.7
2109.5
—
7
20
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
174
0.92
0.08
1.1
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
265
2603
1.02
0.08
1.8
1.9
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
6
70
0.85
0.07
1.0
1.1
—
86.1
—
0
19
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
74
0.81
0.07
1.3
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
156
1.09
0.07
1.9
1.4
e6/l
10254.9
77153.3
0.86
11
109
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
75
1.06
0.07
1.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
77
1.04
0.07
1.3
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
98
1.12
0.07
1.1
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
78
1.02
0.07
3.8
2.3
—
45166.3
—
0
10
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
154
1507
1.02
0.07
1.3
1.3
au/ml
27.8
35.6
—
7
62
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
41
426
0.96
0.06
2.1
3.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
54
520
1.04
0.06
3.1
3.5
u/ml
920.2
2522.8
0.35
46
438
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
104
0.86
0.06
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
49
506
0.96
0.06
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
51
526
0.97
0.06
2.1
1.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
47
452
1.04
0.06
1.1
1.1
iu/ml
8.8
1106.2
0.61
11
131
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
177
1.07
0.06
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
186
1881
0.98
0.06
1.6
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
364
0.96
0.06
2.0
2.6
ug/min
145.6
124.7
0.05
20
233
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
16
148
1.08
0.05
1.1
1.2
—
7.5
—
0
12
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
109
1.10
0.05
1.4
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
171
1680
1.02
0.05
6.2
9.1
kpa
5.0
5.1
0.84
158
1612
(3027801) Oxygen [Partial pressure] in Arterial blood
171
1680
1.02
0.05
6.2
9.1
kpa
13.1
13.4
0.26
158
1615
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
55
565
0.97
0.05
1.2
1.1
au/ml
8.7
14.9
—
5
37
(3011397) Hemoglobin [Presence] in Urine by Test strip
493
4880
1.01
0.05
3.2
3.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
109
1107
0.98
0.05
3.8
2.6
g/l
67.3
67.3
0.04
103
1044
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
178
1798
0.99
0.05
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
76
774
0.98
0.04
2.0
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
109
0.91
0.04
1.6
3.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
30
311
0.96
0.04
1.6
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
130
1.07
0.04
6.3
6.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
297
2938
1.01
0.04
6.2
4.6
mmol/l
0.8
0.8
0.75
278
2782
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
14
149
0.94
0.04
3.1
4.7
mg/l
10.1
8.4
—
9
125
(1001926) Buprenorphine [Presence] in Urine by Screen method
154
1518
1.01
0.03
1.7
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
176
1772
0.99
0.03
1.6
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
167
1648
1.01
0.03
2.4
2.3
au/ml
18.0
22.1
0.26
13
120
(3027008) Opiates [Presence] in Urine
193
1907
1.01
0.03
1.6
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
189
1900
0.99
0.03
1.6
2.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
147
0.95
0.02
1.4
2.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
15
157
0.95
0.02
1.0
1.1
u/ml
2.5
11.0
—
8
102
(3003396) Base excess in Arterial blood by calculation
169
1673
1.01
0.02
6.2
9.1
mmol/l
1.4
1.0
0.80
122
1323
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
242
1.03
0.01
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
123
1235
0.99
0.01
1.5
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
133
1.05
0.01
1.6
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
50
491
1.02
0.01
1.9
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
39
396
0.98
0.01
1.9
1.7
e6/l
5749.9
11078.9
1.32
32
293
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
31
316
0.98
0.01
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
193
1915
1.01
0.01
1.6
2.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
206
0.97
0.01
3.4
2.7
e6/l
605.7
744.3
—
6
66
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
126
0.95
0.01
1.3
1.5
u/l
9.6
4.4
—
7
62
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
74
745
0.99
0.01
2.0
1.4
u/ml
206.0
229.3
0.29
42
423
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
348
3478
1.00
0.01
1.7
1.7
%
1.3
1.4
1.74
317
3126
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
243
1.03
0.00
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
265
2635
1.00
0.00
1.8
1.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
35
343
1.02
0.00
1.6
1.6
mmol/l
7.2
7.5
0.50
22
202
(3020876) Protein [Mass/time] in 24 hour Urine
13
124
1.05
0.00
1.8
2.1
—
2.5
—
0
14
(3036071) Salmonella sp Ab [Titer] in Serum
11
113
0.97
0.00
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
96
1.04
0.00
2.2
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
199
1.00
0.00
1.6
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
254
1.02
0.00
1.7
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
102
0.98
0.00
3.0
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
102
0.98
0.00
3.0
2.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
512
0.99
0.00
10.6
6.8
iu/ml
250.0
279.9
—
5
64
(40768795) Lymph node Pathology biopsy report
18
181
0.99
0.00
1.4
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
213
0.98
0.00
2.0
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
198
1.01
0.00
1.6
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
245
1.02
0.00
1.2
1.3
nmol/l
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
111
0.99
0.00
1.5
1.4
nmol/l
141.8
135.8
0.11
11
111
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
105
1.04
0.00
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
27
269
1.00
0.00
3.2
3.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
30
300
1.00
0.00
1.0
1.1
g/l
1.4
1.5
0.20
30
273
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
52
518
1.00
0.00
1.5
1.4
u/l
21.0
21.7
0.05
39
442
(3036489) Thrombin time
96
952
1.01
0.00
3.9
3.2
s
20.9
21.3
0.73
80
835
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
44
440
1.00
0.00
1.4
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
440
1.00
0.00
1.2
1.8
g/l
9.1
10.1
1.08
36
389
(3028707) Methadone [Presence] in Urine by Screen method
88
873
1.01
0.00
1.9
2.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
294
1.02
0.00
1.6
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
26
255
1.02
0.00
1.8
2.2
mmol/l
66.1
70.7
0.21
21
222
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
235
1.02
0.00
1.6
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
78
780
1.00
0.00
14.3
4.8
kpa
9.6
9.4
0.48
73
742
(3012565) Volume of 24 hour Urine
10
103
0.97
0.00
1.6
2.4
ml
2136.5
2040.2
—
10
95
(3016650) Hepatitis A virus Ab [Presence] in Serum
44
443
0.99
0.00
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
56
562
0.99
0.00
3.4
3.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
98
1.02
0.00
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
244
1.02
0.00
1.3
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
97
0.92
0.00
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
68
0.88
0.00
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
81
0.98
0.00
1.3
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
58.2
—
0
5
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
1246.3
—
0
8
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
4.6
—
0
7
(3034614) HLA Ag [Interpretation]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
69
0.87
0.00
3.8
3.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.1
—
0.3
—
0
7
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
93.4
—
0
5
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
69
0.87
0.00
1.0
1.1
—
70.2
—
0
19
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
81
0.98
0.00
1.3
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
8
82
0.97
0.00
1.3
1.2
—
64.5
—
0
11
(4133840)
6
63
0.95
0.00
1.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MN_RETRGN and mortality.

Females

Parameter HR [95% CI] p-value
K11_MN_RETRGN 0.672 [0.55, 0.82] < 0.001
Birth year 0.993 [0.98, 1.0] 0.098

During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 24333 females with K11_MN_RETRGN died.

Males

Parameter HR [95% CI] p-value
K11_MN_RETRGN 0.617 [0.5, 0.76] < 0.001
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 140 out of 22122 males with K11_MN_RETRGN died.

Mortality risk

Mortality risk for people of age

years, who have K11_MN_RETRGN.

N-year risk Females Males
1 0.071% 0.101%
5 0.414% 0.666%
10 0.931% 1.732%
15 1.766% 3.259%
20 3.271% 5.687%

Relationships between endpoints

↥

Index endpoint: K11_MN_RETRGN – Mandibular retrognathia

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data